264 related articles for article (PubMed ID: 30550948)
1. Distinct regulation pattern of Egr-1, BDNF and Arc during morphine-withdrawal conditioned place aversion paradigm: Role of glucocorticoids.
García-Pérez D; Ferenczi S; Kovács KJ; Milanés MV
Behav Brain Res; 2019 Mar; 360():244-254. PubMed ID: 30550948
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid Homeostasis in the Dentate Gyrus Is Essential for Opiate Withdrawal-Associated Memories.
García-Pérez D; Ferenczi S; Kovács KJ; Laorden ML; Milanés MV; Núñez C
Mol Neurobiol; 2017 Oct; 54(8):6523-6541. PubMed ID: 27730515
[TBL] [Abstract][Full Text] [Related]
3. Different contribution of glucocorticoids in the basolateral amygdala to the formation and expression of opiate withdrawal-associated memories.
García-Pérez D; Ferenczi S; Kovács KJ; Laorden ML; Milanés MV; Núñez C
Psychoneuroendocrinology; 2016 Dec; 74():350-362. PubMed ID: 27728875
[TBL] [Abstract][Full Text] [Related]
4. Conditioned aversive memory associated with morphine withdrawal increases brain-derived neurotrophic factor in dentate gyrus and basolateral amygdala.
Martínez-Laorden E; Navarro-Zaragoza J; Milanés MV; Laorden ML; Almela P
Addict Biol; 2020 Jul; 25(4):e12792. PubMed ID: 31282111
[TBL] [Abstract][Full Text] [Related]
5. Formation of aversive memories associated with conditioned drug withdrawal requires BDNF expression in the amygdala in acute morphine-dependent rats.
Ju YY; Long JD; Liu Y; Liu JG
Acta Pharmacol Sin; 2015 Dec; 36(12):1437-43. PubMed ID: 26567727
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern of neural synaptic plasticity marker-Arc in different brain regions induced by conditioned drug withdrawal from acute morphine-dependent rats.
Li M; Hou YY; Lu B; Chen J; Chi ZQ; Liu JG
Acta Pharmacol Sin; 2009 Mar; 30(3):282-90. PubMed ID: 19262551
[TBL] [Abstract][Full Text] [Related]
7. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice.
Valero E; Gómez-Milanés I; Almela P; Ribeiro Do Couto B; Laorden ML; Milanés MV; Núñez C
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):102-114. PubMed ID: 29407532
[TBL] [Abstract][Full Text] [Related]
8. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
[TBL] [Abstract][Full Text] [Related]
10. Role of glucocorticoids on noradrenergic and dopaminergic neurotransmission within the basolateral amygdala and dentate gyrus during morphine withdrawal place aversion.
García-Pérez D; Milanés MV
Addict Biol; 2020 Mar; 25(2):e12728. PubMed ID: 30784175
[TBL] [Abstract][Full Text] [Related]
11. Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: Role of HPA axis.
Navarro-Zaragoza J; Martínez-Laorden E; Teruel-Fernández FJ; Gómez-Murcia V; Cánovas A; Milanés MV; Laorden ML; Almela P
Pharmacol Biochem Behav; 2021 Feb; 201():173106. PubMed ID: 33444599
[TBL] [Abstract][Full Text] [Related]
12. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
Azar MR; Jones BC; Schulteis G
Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
14. Extinction of aversive memories associated with morphine withdrawal requires ERK-mediated epigenetic regulation of brain-derived neurotrophic factor transcription in the rat ventromedial prefrontal cortex.
Wang WS; Kang S; Liu WT; Li M; Liu Y; Yu C; Chen J; Chi ZQ; He L; Liu JG
J Neurosci; 2012 Oct; 32(40):13763-75. PubMed ID: 23035088
[TBL] [Abstract][Full Text] [Related]
15. Noradrenergic and corticosteroid receptors regulate somatic and motivational symptoms of morphine withdrawal.
Solecki WB; Kus N; Gralec K; Klasa A; Pradel K; Przewłocki R
Behav Brain Res; 2019 Mar; 360():146-157. PubMed ID: 30500430
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors.
Souza AJ; Guimarães FS; Gomes FV
Behav Brain Res; 2023 Jul; 450():114504. PubMed ID: 37209879
[TBL] [Abstract][Full Text] [Related]
17. Persistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate Withdrawal.
Kaufling J; Aston-Jones G
J Neurosci; 2015 Jul; 35(28):10290-303. PubMed ID: 26180204
[TBL] [Abstract][Full Text] [Related]
18. Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats.
Li Y; Liu X; Chen H; Deng H; Xiang X; Chen H; Hao W
Addict Biol; 2007 Sep; 12(3-4):470-7. PubMed ID: 17678507
[TBL] [Abstract][Full Text] [Related]
19. BDNF signaling in the VTA links the drug-dependent state to drug withdrawal aversions.
Vargas-Perez H; Bahi A; Bufalino MR; Ting-A-Kee R; Maal-Bared G; Lam J; Fahmy A; Clarke L; Blanchard JK; Larsen BR; Steffensen S; Dreyer JL; van der Kooy D
J Neurosci; 2014 Jun; 34(23):7899-909. PubMed ID: 24899712
[TBL] [Abstract][Full Text] [Related]
20. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Psychopharmacology (Berl); 2003 Oct; 170(1):80-8. PubMed ID: 12768272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
